MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset hypertrophic cardiomyopathy

Neurogenetics
Felix DistelmaierThomas Klopstock

Abstract

Defects in mitochondrial translation may lead to combined respiratory chain deficiency and typically cause childhood-onset multisystem disease. Only recently, a homozygous missense mutation (c.467T > G, p.Leu156Arg) in MRPL44, encoding a protein of the large subunit of the mitochondrial ribosome, has been identified in two siblings with hypertrophic cardiomyopathy. Using exome sequencing, we identified two further unrelated patients harboring the previously reported mutation c.467T > G, p.Leu156Arg in MRPL44 in the homozygous state and compound heterozygous with a novel missense mutation c.233G > A, p.Arg78Gln, respectively. Both patients presented with childhood-onset hypertrophic cardiomyopathy, which seems to be the core clinical feature associated with MRPL44 deficiency. However, we observed several additional clinical signs and symptoms including pigmentary retinopathy, hemiplegic migraine, Leigh-like lesions on brain MRI, renal insufficiency, and hepatopathy. Our findings expand the clinical spectrum associated with MRPL44 mutations and indicate that MRPL44-associated mitochondrial dysfunction can also manifest as a progressive multisystem disease with central nervous system involvement. Of note, neurological and neuro-op...Continue Reading

References

May 12, 2009·Methods in Enzymology·M ElstnerH Prokisch
Jul 26, 2011·Human Mutation·Louise GalmicheAgnès Rötig
Nov 3, 2011·The EMBO Journal·Benedetta RuzzenenteNils-Göran Larsson

❮ Previous
Next ❯

Citations

Nov 1, 2015·The Canadian Journal of Cardiology·Catherine Brunel-GuittonFlorin Sasarman
Mar 26, 2016·Korean Circulation Journal·Josef Finsterer, Claudia Stöllberger
Jun 23, 2016·Human Molecular Genetics·Benedetta RuzzenenteMetodi D Metodiev
Aug 10, 2016·Frontiers in Cardiovascular Medicine·Ayman W El-Hattab, Fernando Scaglia
Nov 5, 2015·Nature Reviews. Molecular Cell Biology·Ricarda Richter-DennerleinPeter Rehling
Aug 10, 2016·Metabolic Brain Disease·Fabian BaertlingFelix Distelmaier
Sep 7, 2019·International Journal of Molecular Sciences·Andreas BrodehlHendrik Milting
Jul 8, 2018·Essays in Biochemistry·Veronika BoczonadiRita Horvath
May 19, 2017·Biomedical Reports·Josef Finsterer, Fulvio Alexandre Scorza
Nov 27, 2020·International Journal of Molecular Sciences·Guomin HuangHong Zhang
Dec 15, 2020·FEBS Letters·Alberto FerrariAntoni Barrientos
Jan 10, 2021·Trends in Cell Biology·Priyanka MaitiRicarda Richter-Dennerlein
Feb 15, 2021·Journal of Inherited Metabolic Disease·Hind AlsharhanChristina Lam
Mar 21, 2021·Molecular Biology Reports·Alejandro HorgaHenry Houlden
Nov 30, 2019·Trends in Biochemical Sciences·Florent Waltz, Philippe Giegé
May 1, 2021·International Journal of Molecular Sciences·Maria Isabel G Lopez SanchezJoanna Rorbach
May 20, 2021·American Journal of Medical Genetics. Part a·Hind AlsharhanRebecca D Ganetzky
Jun 3, 2021·International Journal of Molecular Sciences·Cristina MazzaccaraGiulia Frisso
Jun 19, 2021·Molecular Genetics and Metabolism·Marisa W FriederichJohan L K Van Hove

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.